Search Results 1-10 of 978 for %EB%8D%95%EC%82%B0%20%EC%98%A8%EC%B2%9C%20%EC%88%99%EB%B0%95%EF%BC%88KaKaotalk:Za31%EF%BC%8924%EC%8B%9C%EA%B0%84%20%EB%A7%88%EC%9D%8C%EC%A0%84%EB%AC%B8%EA%B0%80

  1. National Center for Data to Health CD2H.

  3. ... EA ADD HR,162 260000007,HC IV INF THER INIT 1ST HR,369 260000008,HC IV PUSH EA ADD SEQ DRUG,171 260000009,HC IV PUSH EA ADD SEQ NEW DRUG,140 260000010,HC ...

  4. ... 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe,173.6 636000003,43528000305,hepatitis B vaccine 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe,173.6 ...

  5. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other ...

  6. ... 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe,173.6 636000003,43528000305,hepatitis B vaccine 20 mcg/0.5 mL-adjuvant CpG 1018 (PF) IM syringe,173.6 ...

  7. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  8. A Study to Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The primary purpose of this study is to evaluate the safety and effectiveness of TAK-981 in combination with anti-CD38 monoclonal ...

  9. https://www.mayoclinic.org/arabic_procedure_concepts.xml

    ... 20:58-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/tests-procedures/birth-control-patch/about/pac-20384553 ...

  10. NOLA (NeuWave Observational Liver Ablation) Registry - Mayo Clinic

    Jacksonville, Florida: 20-001795. NCT ID ... Patients with signed informed consent (or waiver approved by IRB/EC) ... Eligibility last updated 12/20/21.